Translating biomarkers to clinical practice

Area of Science:

• Psychiatric research
• Biomarker discovery and validation

Background:

• Biomarkers are measurable indicators of disease risk, progression, or treatment response.
• The translation of identified biomarkers into clinical practice is often overlooked in psychiatric literature.
• Existing frameworks for diagnostic development may not be widely known to psychiatric researchers.

Purpose of the Study:

• To provide a comprehensive overview of the steps following biomarker identification in psychiatry.
• To bridge the knowledge gap regarding biomarker validation for clinical use.
• To guide psychiatric researchers in translating putative biomarkers into clinical practice.

Main Methods:

• Review of standard approaches for characterizing biomarker performance.
• Examination of methods to demonstrate clinical relevance of biomarkers.
• Discussion of validation strategies for biomarker-based tests, including efficacy and cost-effectiveness.

Main Results:

• Standardized methods exist for assessing biomarker performance metrics.
• Clinical relevance can be demonstrated through rigorous evaluation and comparison.
• Validation requires assessing not only accuracy but also clinical utility and economic viability.

Conclusions:

• A structured approach is essential for the successful clinical translation of psychiatric biomarkers.
• Understanding biomarker validation pathways is crucial for advancing psychiatric diagnostics and therapeutics.
• Further attention to the practicalities of biomarker implementation is needed in psychiatric research.